Oseltamivir resistance during treatment of influenza A (H5N1) infection.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 16371632.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Influenza A (H5N1) virus with an amino acid substitution in neuraminidase conferring high-level resistance to oseltamivir was isolated from two of eight Vietnamese patients during oseltamivir treatment. Both patients died of influenza A (H5N1) virus infection, despite early initiation of treatment in one patient. Surviving patients had rapid declines in the viral load to undetectable levels during treatment. These observations suggest that resistance can emerge during the currently recommended regimen of oseltamivir therapy and may be associated with clinical deterioration and that the strategy for the treatment of influenza A (H5N1) virus infection should include additional antiviral agents.
Medical subject headings
- Acetamides
- Antiviral Agents
- Drug Resistance, Viral
- Influenza A Virus, H5N1 Subtype
- Influenza, Human
- Neuraminidase